Access My Breast Cancer Care App

NCT07696637 | Recruiting

• 1 other identifier: H25-03017
• Study Type: interventional
• Target: 148
• Locations: 1 country
• Sites: 2

Brief Summary

The Access my Breast Cancer Care application was developed by a multidisciplinary team with the intention of providing breast cancer patients with a centralized area to navigate their journey. Several of the research team members (Dr. Macadam, Dr. Isaac, Selena (CNS) and Pauline (CNS)) provided clinical expertise to ensure accuracy of clinical content. The application houses educational resources, a calendar, symptom tracker, customizable care pathway, community forum and a chat feature. The study will be designed as a randomized controlled trial (RCT) to measure the effect of the application on patient-centered outcomes of 1) satisfaction with care 2) reduction in adverse events, 3) usability. The investigators will conduct focus groups to understand the benefit of the app from the patient perspective.

Conditions

Breast Reconstruction; Breast Cancer

Outcome Measures

Primary Outcomes (1)

• Does access to a centralized breast cancer app improve patient navigation during breast cancer reconstruction journey

  Assessment will be made using BREAST-Q scores. The BREAST-Q is a patient-reported outcome measure where higher scores (0-100) indicate better quality of life or satisfaction.

  1 month and 6 months

Secondary Outcomes (2)

• Does the app improve reduce the amount of emergency room visits?

  1 month and 6 months

• Does the app reduce wait times to specialist review?

  1 month and 6 month

Study Arms (2)

Control

ACTIVE COMPARATOR

This arm will undergo standard breast cancer care without access to the app

Other: Standard Pathway

App

EXPERIMENTAL

This arm will undergo standard breast cancer care with access to the app

Other: Access My Breast Cancer Care App

Interventions

Access My Breast Cancer Care App OTHER

App designed by our VCH team for patients with breast cancer to navigate their care pathways

App

Standard Pathway OTHER

These patients will undergo standard breast cancer care without access to the app

Control

Eligibility Criteria

• Age: 19 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• You are at least 19 years of age (the team only treats adult patients)
• You have a diagnosis of breast cancer, or a BRCA mutation, and will be -having breast surgery with reconstruction (the app is tailored the breast cancer journey)
• You have access to a smartphone or computer (individuals participating in the study will require access to a smart phone or computer to access the application if randomized to the intervention group)
• Must have basic reading skills in English (the app is only available in English language)

You may not qualify if:

• You do not have access to a smartphone or computer (a computer or smart phone is required to access the application)
• You are \<19 years of age (the team does not treat pediatric patients)
• You do not have breast cancer or a BRCA mutation (the application is specific to the breast cancer journey)
• You decline breast reconstruction (the application was designed by the plastics and reconstructive team, and with the app being in an infancy stage, the bulk of the content focuses on breast reconstruction surgery)
• You are not able to read English (the app is only available in English language)

Sponsors & Collaborators

• University of British Columbia: lead

Study Sites (2)

Providence Health Care

Vancouver, British Columbia, Canada

RECRUITING

Vancouver Coastal Health

Vancouver, British Columbia, Canada

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Central Study Contacts

Selena Banser Clinical Nurse Specialist, RN

CONTACT

236-997-9112; selena.banser@vch.ca

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor, P. Clugston Chair of Breast Reconstruction, Plastic and Reconstructive Surgeon

Study Record Dates

• First Submitted: April 7, 2026
• First Posted: July 10, 2026
• Study Start: April 20, 2026
• Primary Completion (Estimated): September 1, 2027
• Study Completion (Estimated): September 1, 2027
• Last Updated: July 10, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will share

Locations

CA (2)